about
High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III.Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting.Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).Effects of a behavioral intervention that emphasizes spices and herbs on adherence to recommended sodium intake: results of the SPICE randomized clinical trial.Effect of glycemic index and carbohydrate intake on kidney function in healthy adults.Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.The effects of weight change on glomerular filtration rate.Bariatric surgery is associated with improvement in kidney outcomes.Lifestyle-related factors, obesity, and incident microalbuminuria: the CARDIA (Coronary Artery Risk Development in Young Adults) study.Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER studyA within-patient analysis for time-varying risk factors of CKD progression.Dietary Sources of Phosphorus among Adults in the United States: Results from NHANES 2001-2014.Acute Kidney Injury in Patients on SGLT2 Inhibitors: A Propensity-Matched Analysis.Dietary Phosphorus Intake and the Kidney.Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD.Race, Serum Potassium, and Associations With ESRD and Mortality.Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.Bariatric Surgery and Kidney-Related Outcomes.Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes.Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial.Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.Public health: Effects of sodium and potassium intake on health outcomes.Phosphorus content of popular beverages.Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation.Risk Factors for Prognosis in Patients With Severely Decreased GFR.Target Blood Pressure for Cardiovascular Disease Prevention in Patients with CKDAssociation of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort StudyCKD progression: a risky businessFluid Intake for Kidney Disease Prevention: An Urban Myth?Should eGFR and Albuminuria Be Added to the Framingham Risk Score? Chronic Kidney Disease and Cardiovascular Disease Risk PredictionImproving proteinuria screening with mailed smartphone urinalysis testing in previously unscreened patients with hypertension: a randomized controlled trialMetabolically Healthy Obesity and Risk of Kidney Function DeclineKidney Function in Obesity-Challenges in Indexing and EstimationRisk Factors and Outcomes of Rapid Correction of Severe HyponatremiaAssociations of Opioid Prescriptions with Death and Hospitalization across the Spectrum of Estimated GFR
P50
Q30564821-24B33E27-BC3D-4D89-A717-D0CD95FFD743Q34254746-01293F8D-3AA2-4C71-82BF-6A46DAF86645Q35118016-A6263B68-7108-4999-9EBF-74A56D206E44Q35992567-EE309565-8512-4FE2-86C8-EF82C9092CECQ36071343-6B006EE0-0CF0-4F7B-86EA-B9F89C498ACFQ36185991-9FFF599F-1026-450E-94B9-BC18D25B6FA0Q36197733-85D9E583-29FC-4144-B266-214DF9805A5AQ37017318-12300C00-8602-4AFC-80C6-185581EF0986Q37038868-7729EF9A-C348-4D3B-9C0A-A116BFCC5BFAQ37258125-C36DD63A-7F17-4C1A-A2C2-204C5346D2C0Q37604738-3F3CEDFF-265C-4D4D-B047-3831E506E851Q37673108-6DEDFBE0-11EB-4817-B57E-0FBAE8362E3BQ38615440-0A2DFD25-F60D-4EB8-B5C0-8D932F318B20Q38725971-B4947DAA-BB9A-4A24-BFA6-2D5FADC200EEQ38760938-05E1E06C-7B35-4380-9800-0BDF29C6C61CQ38864040-DE42AB30-03EA-4226-8B3A-CED934716081Q40116112-643583EC-55B7-49D7-8A09-001B0DA0D57BQ40229384-91BDFDB4-DA74-4EE5-9F16-CE06514A1CA5Q40443306-8C5A8493-D920-4B7C-94FC-FC02BC0EFF05Q40466580-CA7FBB45-CA66-40AC-AAFC-5A0ED41E1572Q40631743-BE901E90-268A-4428-8C76-1D315FA94458Q44795252-9B984FD3-2C9F-42FC-A2C7-654C05C15210Q45969081-32B73DEC-5BE1-4371-A012-B294BB3133F7Q50081190-4D7716A3-98AB-4F8B-9B8E-F4ACB3EA21D9Q55016359-85B58FA2-9730-42F4-A839-F0DCF159BEC7Q57293941-49568D39-0B78-4753-A757-B6D04306E2ABQ59831098-AF247505-9A19-472B-BDDA-0616B5915C0EQ60777178-17D43218-6DB3-4582-8F8B-3371415D8325Q60777188-195147AF-0552-48F8-A73B-41766CCF0E72Q60777189-D94DFCC6-902B-4A7C-956E-F4DA86038845Q64101863-AA98FF65-A050-4328-9C8D-F2697A8364F6Q87935711-50B6D048-6F06-41BA-BE79-8279F36475E7Q87941338-9D4CFA47-1421-4BFF-ADD9-3376FBC61CC0Q89000045-8DA9B4D8-DE02-4E8C-91ED-B9B6DDAA2520Q90466186-78F82E75-18CC-4A8B-9A7F-3BCF2DEFE9D1
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-8114-7447
@en
name
Alex R Chang
@ast
Alex R Chang
@en
Alex R Chang
@es
Alex R Chang
@nl
type
label
Alex R Chang
@ast
Alex R Chang
@en
Alex R Chang
@es
Alex R Chang
@nl
prefLabel
Alex R Chang
@ast
Alex R Chang
@en
Alex R Chang
@es
Alex R Chang
@nl
P106
P1153
55649305800
P31
P496
0000-0002-8114-7447